journal
MENU ▼
Read by QxMD icon Read
search

Journal of Heart and Lung Transplantation

journal
https://www.readbyqxmd.com/read/30093178/erratum
#1
(no author information available yet)
No abstract text is available yet for this article.
August 6, 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/30100327/hydrogen-gas-inhalation-during-ex-vivo-lung-perfusion-of-donor-lungs-recovered-after-cardiac-death
#2
Seokjin Haam, Jin Gu Lee, Hyo Chae Paik, Moo Suk Park, Beom Jin Lim
BACKGROUND: Ex vivo lung perfusion (EVLP) is a system that circulates normothermic perfusate into procured lungs, allowing for improved lung function and lung assessment. We investigated whether ventilation with hydrogen gas during EVLP improves the donation after cardiac death lung function and whether this effect persists after actual transplantation. METHODS: Ten pigs were randomly divided into a control group (n = 5) and a hydrogen group (n = 5). No treatment was administered to induce warm ischemic injury for 1 hour after cardiac arrest, and EVLP was applied in procured lungs for 4 hours...
June 21, 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/30037729/impact-of-the-initiation-of-balloon-pulmonary-angioplasty-program-on-referral-of-patients-with-chronic-thromboembolic-pulmonary-hypertension-to-surgery
#3
Myriam Amsallem, Julien Guihaire, Jennifer Arthur Ataam, Lilia Lamrani, David Boulate, Sacha Mussot, Dominique Fabre, Yu Taniguchi, Francois Haddad, Olivier Sitbon, Xavier Jais, Marc Humbert, Gérald Simonneau, Olaf Mercier, Philippe Brenot, Elie Fadel
BACKGROUND: Balloon pulmonary angioplasty (BPA) is a technique proposed for inoperable patients with chronic thromboembolic pulmonary hypertension (CTEPH). In this study we aimed to determine whether initiation of the BPA program has modified the characteristics and outcome of patients undergoing pulmonary endarterectomy (PEA), and compared the characteristics of patients undergoing one or the other procedure. METHODS: This prospective registry study included all patients with CTEPH who underwent PEA in the French National Reference Center before (2012 to 2013) and after (2015 to 2016) BPA program initiation (February 2014)...
May 24, 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/30055812/transplant-phenomapping-a-move-toward-personalized-immunosuppression
#4
EDITORIAL
Robert J H Miller, Kiran K Khush
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/30055811/oxygen-supplementation-for-pulmonary-arterial-hypertension-clues-from-the-reveal-registry
#5
EDITORIAL
Carmine Dario Vizza, Roberto Badagliacca
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29958769/reinitiation-of-centrifugal-ventricular-assist-device-support-after-failed-attempt-at-cardiac-recovery
#6
LETTER
Svetlana B Shugh, Hari P Tunuguntla, Aamir Jeewa, Barbara A Elias, Iki Adachi
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29937215/extracellular-dna-in-plasma-from-marking-to-dissecting-the-cell-biology-of-cardiac-transplants
#7
EDITORIAL
Jeffrey L Platt, Trey D Williams, Marilia Cascalho
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29936085/bloodstream-infections-in-mechanical-circulatory-support-device-recipients-in-the-international-society-of-heart-and-lung-transplantation-mechanically-assisted-circulation-support-registry-epidemiology-risk-factors-and-mortality
#8
Saima Aslam, Rongbing Xie, Jennifer Cowger, James K Kirklin, Vivian H Chu, Stephan Schueler, Theo de By, Kate Gould, Orla Morrissey, Lars H Lund, Stanley Martin, Daniel Goldstein, Margaret Hannan
BACKGROUND: We used multicenter international data from the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support (IMACS) registry to determine bloodstream infection (BSI) event rate, independent risk factors, and association with mortality. METHODS: Included were patients registered in IMACS from January 2013 through December 2015, assessed BSI event rate of mechanical circulatory support (MCS) and non-MCS-related BSIs, and conducted univariate and multivariate analyses between BSI with baseline characteristics and mortality...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29933912/circulating-cell-free-dna-as-a-biomarker-of-tissue-injury-assessment-in-a-cardiac-xenotransplantation-model
#9
Sean Agbor-Enoh, Joshua L Chan, Avneesh Singh, Ilker Tunc, Sasha Gorham, Jun Zhu, Mehdi Pirooznia, Philip C Corcoran, Marvin L Thomas, Billeta G T Lewis, Moon Kyoo Jang, David L Ayares, Keith A Horvath, Muhammad M Mohiuddin, Hannah Valantine
BACKGROUND: Observational studies suggest that cell-free DNA (cfDNA) is a biomarker of tissue injury in a range of conditions including organ transplantation. However, the lack of model systems to study cfDNA and its relevance to tissue injury has limited the advancements in this field. We hypothesized that the predictable course of acute humoral xenograft rejection (AHXR) in organ transplants from genetically engineered donors provides an ideal system for assessing circulating cfDNA as a marker of tissue injury...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29907501/danazol-treatment-of-gastrointestinal-bleeding-in-left-ventricular-assist-device-supported-patients
#10
LETTER
Sarah Schettle, Badr Al Bawardy, Rabea Asleh, Saadia Sherazi, Elizabeth Rajan, John Stulak, Naveen Pereira
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29802085/clinical-phenomapping-and-outcomes-after-heart-transplantation
#11
Maral Bakir, Nicholas J Jackson, Simon X Han, Alex Bui, Eleanor Chang, David A Liem, Abbas Ardehali, Reza Ardehali, Arnold S Baas, Marcella Calfon Press, Daniel Cruz, Mario C Deng, Eugene C DePasquale, Gregg C Fonarow, Tam Khuu, Murray H Kwon, Bernard M Kubak, Ali Nsair, Jennifer L Phung, Elaine F Reed, Joanna M Schaenman, Richard J Shemin, Qiuheng J Zhang, Chi-Hong Tseng, Martin Cadeiras
BACKGROUND: Survival after heart transplantation (HTx) is limited by complications related to alloreactivity, immune suppression, and adverse effects of pharmacologic therapies. We hypothesize that time-dependent phenomapping of clinical and molecular data sets is a valuable approach to clinical assessments and guiding medical management to improve outcomes. METHODS: We analyzed clinical, therapeutic, biomarker, and outcome data from 94 adult HTx patients and 1,557 clinical encounters performed between January 2010 and April 2013...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29802082/plasma-exchange-to-remove-heparin-induced-thrombocytopenia-antibodies-and-the-use-of-heparin-during-cardiopulmonary-bypass-in-critically-ill-cardiac-patients
#12
LETTER
Bhavadharini Ramu, Rebecca J Cogswell, Mark T Reding, Ranjit John, Cindy M Martin
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29802081/donor-heart-selection-and-outcomes-an-analysis-of-over-2-000-cases
#13
Arezu Z Aliabadi-Zuckermann, Johannes Gökler, Alexandra Kaider, Julia Riebandt, Roxana Moayedifar, Emilio Osorio, Thomas Haberl, Phillipp Angleitner, Günther Laufer, John Forsythe, Ivan Knezevic, Bosko Skoric, Michiel Erasmus, Johan van Cleemput, Kadir Caliskan, Nicolaas De Jonge, Zoltan Szabolcs, Zsolt Prodán, Andrä Wasler, Christoph Bara, Mario Udovičić, Tim Sandhaus, Jens Garbade, Arjang Ruhparwar, Felix Schoenrath, Stephan Hirt, Herwig Antretter, Uwe Schulz, Manfred Richter, Josef Thul, Markus J Barten, Assad Haneya, Ivan Aleksic, Sandra Eifert, Michael Berchtold-Herz, Jacqueline Smits, Andreas O Zuckermann
BACKGROUND: Decision-making when offered a donor heart for transplantation is complex, and supportive data describing outcomes according to acceptance or non-acceptance choices are sparse. Our aim was to analyze donor heart acceptance decisions and associated outcomes at a single center, and after subsequent acceptance elsewhere. METHODS: This investigation was a retrospective analysis of data obtained from the University of Vienna Medical Center and Eurotransplant centers for the period 2001 to 2015...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29776812/preservation-with-%C3%AE-1-antitrypsin-improves-primary-graft-function-of-murine-lung-transplants
#14
Jessica Götzfried, Natalia F Smirnova, Carmela Morrone, Brice Korkmaz, Ali Önder Yildirim, Oliver Eickelberg, Dieter E Jenne
BACKGROUND: Vascular damage and primary graft dysfunction increase with prolonged preservation times of transplanted donor lungs. Hence, storage and conservation of donated lungs in protein-free, dextran-containing electrolyte solutions, like Perfadex, is limited to about 6 hours. We hypothesized that transplanted lungs are protected against neutrophil-mediated proteolytic damage by adding α1 -anti-trypsin (AAT), a highly abundant human plasma proteinase inhibitor, to Perfadex. METHODS: A realistic clinically oriented murine model of lung transplantation was used to simulate the ischemia-reperfusion process...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29754764/monitoring-of-early-humoral-immunity-to-identify-lung-recipients-at-risk-for-development-of-serious-infections-a-multicenter-prospective-study
#15
Elizabeth Sarmiento, Jose Cifrian, Leticia Calahorra, Carles Bravo, Sonia Lopez, Rosalia Laporta, Piedad Ussetti, Amparo Sole, Carmen Morales, Alicia de Pablos, Maria Jaramillo, Ikram Ezzahouri, Sandra García, Joaquin Navarro, Marcos Lopez-Hoyos, Javier Carbone
BACKGROUND: Infection is still a leading cause of death during the first year after lung transplantation. We performed a multicenter study among teaching hospitals to assess monitoring of early humoral immunity as a means of identifying lung recipients at risk of serious infections. METHODS: We prospectively analyzed 82 adult lung recipients at 5 centers in Spain. Data were collected before transplantation and at 7 and 30 days after transplantation. Biomarkers included IgG, IgM, IgA, complement factors C3 and C4, titers of antibodies to pneumococcal polysaccharide antigens (IgG, IgA, IgM) and antibodies to cytomegalovirus (IgG), and serum B-cell activating factor (BAFF) levels...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29754763/importance-and-clinical-implications-of-new-methods-for-grading-aortic-valve-regurgitation-in-patients-supported-with-a-continuous-flow-left-ventricular-assist-devices
#16
LETTER
Angelo M Dell'Aquila, Henryk Welp
No abstract text is available yet for this article.
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29706574/early-detection-of-cardiac-allograft-vasculopathy-using-highly-automated-3-dimensional-optical-coherence-tomography-analysis
#17
Michal Pazdernik, Zhi Chen, Helena Bedanova, Josef Kautzner, Vojtech Melenovsky, Vladimir Karmazin, Ivan Malek, Ales Tomasek, Eva Ozabalova, Jan Krejci, Janka Franekova, Andreas Wahle, Honghai Zhang, Tomas Kovarnik, Milan Sonka
BACKGROUND: Optical coherence tomography (OCT)-based studies of cardiac allograft vasculopathy (CAV) published thus far have focused mainly on frame-based qualitative analysis of the vascular wall. Full capabilities of this inherently 3-dimensional (3D) imaging modality to quantify CAV have not been fully exploited. METHODS: Coronary OCT imaging was performed at 1 month and 12 months after heart transplant (HTx) during routine surveillance cardiac catheterization...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29703578/early-in-vivo-experience-with-the-pediatric-continuous-flow-total-artificial-heart
#18
Jamshid H Karimov, David J Horvath, Nicole Byram, Gengo Sunagawa, Barry D Kuban, Shengqiang Gao, Raymond Dessoffy, Kiyotaka Fukamachi
BACKGROUND: Heart transplantation in infants and children is an accepted therapy for end-stage heart failure, but donor organ availability is low and always uncertain. Mechanical circulatory support is another standard option, but there is a lack of intracorporeal devices due to size and functional range. The purpose of this study was to evaluate the in vivo performance of our initial prototype of a pediatric continuous-flow total artificial heart (P-CFTAH), comprising a dual pump with one motor and one rotating assembly, supported by a hydrodynamic bearing...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29653800/use-of-supplemental-oxygen-in-patients-with-pulmonary-arterial-hypertension-in-reveal
#19
Harrison W Farber, David B Badesch, Raymond L Benza, C Gregory Elliott, Robert P Frantz, Michael D McGoon, Mona Selej, Carol Zhao, Adaani E Frost
BACKGROUND: Supplemental low-flow oxygen is recommended by treatment guidelines as supportive therapy for patients with pulmonary arterial hypertension (PAH), based largely on expert opinion. Reduced diffusing capacity of lung carbon monoxide (DLCO) is associated with increased mortality in PAH. Reduced DLCO is also associated with relative hypoxemia, making the effects of supplemental oxygen use of particular interest in this sub-population. METHODS: Patients in the Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL), a 5-year observational study of Group 1 PAH, were categorized by presence or absence of supplemental oxygen use and by degree of DLCO reduction...
August 2018: Journal of Heart and Lung Transplantation
https://www.readbyqxmd.com/read/29650295/acquired-von-willebrand-syndrome-and-impaired-platelet-function-during-venovenous-extracorporeal-membrane-oxygenation-rapid-onset-and-fast-recovery
#20
Johannes Kalbhenn, Axel Schlagenhauf, Simone Rosenfelder, Axel Schmutz, Barbara Zieger
BACKGROUND: Bleeding contributes to the high mortality of venovenous extracorporeal membrane oxygenation (vvECMO). The development of acquired von Willebrand syndrome (AVWS) has been identified as relevant pathology during ECMO. This study was performed to determine the onset of AVWS after implantation and the recovery of von Willebrand factor (VWF) parameters after explantation of ECMO in a large cohort of patients. METHODS: VWF parameters of 59 patients treated with vvECMO at a university ECMO center were obtained before ECMO implantation, during therapy, and after explantation...
August 2018: Journal of Heart and Lung Transplantation
journal
journal
20152
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"